Reply to: Genome-wide linkage analysis of von Willebrand factor plasma levels implicates the ABO locus as a principal determinant: should we overlook ADAMTSI3?

• References

• 1 O'Donnell J, Boulton FE, Manning RA. et al Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-41.
• 2 Levy GG, Nichols WC, Lian EC. et al Mutations in a member of the AD AMTS gene family cause thrombotic thrombocytopenic purpu-ra. Nature 2001; 413: 488-94.
• 3 Souto JC, Almasy L, Muniz-Diaz E. et al Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 2000; 20: 2024-8.
• 4 Souto JC, Almasy L, Soria JM. et al Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project. Thromb Haemost 2003; 89: 468-74.
• 5 Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003; 1: 33-40.
• 6 Schneppenheim R, Budde U, Oyen F. et al Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood 2003; 101: 1845-50.
• 7 Kokame K, Matsumoto M, Soejima K. et al Mutations and common polymorphisms in ADAMTS13 gene responsible for von Wille-brand factor-cleaving protease activity. Proc Natl Acad Sci 2002; 99: 11902-7.